clene.com (CLNN) Narxning foydaga nisbati
Clene Inc. (CLNN) kompaniyasining, PE koeffitsiyenti -2.40 ga teng bo'lgan, ushbu kunlik narxlar grafigi uning neyroprotektor loyihalari pipeline'ining biznes rivojlanishini aks ettiradi. Ta'minot zanjiri ishonchliligi dori vositalarini tashish paytida maxsus harorat rejimi va maydon himoyasi orqali ta'minlanadi. Kompaniyaning iqtisodiy sikllarga chidamliligi uning klinik sinovlarga e'tibor qaratganligi bilan belgilanadi. ALS bemorlari orasidagi yuqori brend obro'si va aksiyadorlarning ishonchi innovatsion nanokristall platformaga asoslangan.
Clene Inc (CLNN) kompaniyasining tahliliy kesimlari
- aksiyalar qiymati va narxlar bo'yicha konsensus prognoz:
- bozor kapitallashuvi tafsilotlari:
- balans kapitallashuvi haqida ma'lumot:
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Qarzning kapitalga nisbati Clene Inc.|CLNN - Uzoq muddatli qarzning o'z kapitaliga nisbati|Qisqa muddatli qarzdorlikning kapitalga nisbati Clene Nanomedicine|CLNN - Kompaniyaning jamlangan qarzlari|Sof aktivlarga qarzlar Clene Inc.|CLNN - Kompaniyaning uzoq muddatli qarzi|Kompaniyaning qisqa muddatli qarzdorligi Clene|Tezkor likvidlik ko‘rsatkichi clene.com
- biznes foydasi va investitsiya koeffitsiyentlari ma'lumotlari:
CLNN - Sof daromad|Kompaniya foydasi prognozi Clene Inc.|CLNN - P/E multiplikatori|Prognoz qilingan narxning foydaga nisbati Clene Nanomedicine|CLNN - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Clene Inc.|CLNN - Foizlar, soliqlar va eskirish to'lanishidan oldingi foyda|So'nggi 12 oy davomida bir aksiya uchun foyda Clene|CLNN - So'nggi o'n ikki oy davomida bir aksiya uchun foyda|So'nggi 12 oy davomida bir aksiya uchun foydaning yillik o'sishi clene.com|CLNN - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun foydaning prognoz qilingan o'sish sur'ati Clene Inc.
Kompaniyaning jamlanma tahlili:Clene Inc.
P/E koeffitsiyenti biznesning bozor qiymatini uning yillik sof foydasiga nisbatan belgilaydi, bu esa investitsiyalarning qoplanish muddati va baholashning moliyaviy hisobotlarga sezgirligini o'lchaydi. GURU.Markets platformasidagi Clene Inc. (CLNN) uchun P/E baholash tendentsiyasi kompaniyaning nanoparticles patentlariga bo'lgan bozor kutuvlarini aks ettiradi, bunda yuqori metrika tebranishlari neyrodegeneratsiyani davolashga qaratilgan biofarmatsevtika ishlanmalarining spekulyativ salohiyatini ta'kidlaydi.
Raqobatdosh kompaniyalar tahlili
Narx-foyda koeffitsiyenti biogen.com (BIIB)|Narxning foydaga nisbati Neurocrine Biosciences, Inc. (NBIX)|Narxning foydaga nisbati RGC (Regencell Bioscience Ltd)|P/E multiplikatori AXSM (Axsome Therapeutics Inc)|ACADIA Corp (ACAD) - Kapitalizatsiyaning foydaga nisbati|XENE - Narxning foydaga nisbati|VKTX (vikingtherapeutics.com) - Narx-foyda multiplikatori|SUPN: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Catalyst Pharma (CPRX)|Narx-foyda koeffitsiyenti DNLI|HRMY: Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori BHVN|Biznesning o‘zini qoplash muddati amylyx.com|Narxning foydaga nisbati Trevi Therapeutics, Inc. TRVI|PRAX: Narx-foyda multiplikatori|Anavex Corp - P/E multiplikatori|CeriBell EEG (CBLL) - Narx-foyda koeffitsiyenti|PRTA (prothena.com) - Narx-foyda koeffitsiyenti|ALEC - Biznesning o‘zini qoplash muddati|ANNX (Annexon) - P/E multiplikatori|Narx-foyda koeffitsiyenti Omeros Corp. (OMER)|Narxning foydaga nisbati Neurogene Corp (NGNE)|Narxning foydaga nisbati ACIU (AC Immune Inc)|Narxning foydaga nisbati Voyager Therapeutics VYGR|NMRA: Narx-foyda multiplikatori|SCLX - Narxning foydaga nisbati|TVGN (Tevogen Bio Holdings Inc.) - Narx-foyda multiplikatori|alphacognition.com (ACOG) - Narxning foydaga nisbati|Narx-foyda multiplikatori CGTX|IKT (Inhibikase Therapeutics) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati cassavasciences.com SAVA|Narx-foyda koeffitsiyenti ASRT (Assertio Holdings, Inc.)|P/E multiplikatori coyatherapeutics.com (COYA)|Narxning foydaga nisbati Vistagen VTGN|Kompaniya qiymatining sof foydaga nisbati OVID|ABOS - Narxning foydaga nisbati|Kapitalizatsiyaning foydaga nisbati cervomed.com|ATHE: P/E multiplikatori|Narx-foyda koeffitsiyenti PepGen|Narxning foydaga nisbati Jupiter Neurosciences|Narxning foydaga nisbati RLMD|P/E multiplikatori ANVS|GRCE - Kapitalizatsiyaning foydaga nisbati|Narxning foydaga nisbati Firefly Neuroscience AIFF|KLTO: Narx-foyda multiplikatori|NeuroSense Therapeutics, Ltd. - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Reviva Pharmaceuticals, Inc.|MTVA (metaviatx.com) - Narx-foyda koeffitsiyenti|neuraxis.com - Kompaniya qiymatining sof foydaga nisbati|HSDT (Helius Medical Technologies, Inc.) - P/E multiplikatori|Passage Bio Corp (PASG) - Biznesning o‘zini qoplash muddati|Narxning foydaga nisbati Neuphoria Therapeutics Inc. (NEUP)|Minerva - Narx-foyda multiplikatori|P/E multiplikatori ATHA (Athira Pharma, Inc.)|ADXN - Narx-foyda koeffitsiyenti|ALZN: Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Cyclerion Therapeutics CYCN|PTIX: P/E multiplikatori|Narx-foyda koeffitsiyenti Pasithea Therapeutics Corp.|Narxning foydaga nisbati Cortigent Inc|Narxning foydaga nisbati ATXI|Narxning foydaga nisbati BrainStorm Cell Therapeutics (BCLI)|Cara Therapeutics Inc. - Narx-foyda multiplikatori|Narxning foydaga nisbati Chromocell Therapeutics Corporation CHRO|ELYM: Narx-foyda multiplikatori|ITCI - Narxning foydaga nisbati|LBPH (longboardpharma.com) - Narx-foyda multiplikatori|MRNS: P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati NKGen Biotech Inc (NKGN)|Narx-foyda koeffitsiyenti NRBO|P/E multiplikatori Sage Therapeutics Inc|Narxning foydaga nisbati Synaptogenix, Inc. (SNPX)|TRVN (trevena.com) - Kompaniya qiymatining sof foydaga nisbati|Narxning foydaga nisbati Vigil Neuroscience, Inc. VIGL|anewmeds.com (WENA) - Kapitalizatsiyaning foydaga nisbati|Cerevel - P/E multiplikatori
